Business Context and Reporting Period
This Form 8-K is filed by PharmAthene, Inc. (not Altimmune, Inc.) on December 2, 2013. The report addresses a legal matter previously disclosed on November 29, 2013, involving a lawsuit filed against the company and its Board of Directors by Prescott Group Capital Management and related entities in the Court of Chancery of the State of Delaware.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a legal event and contains no financial performance data.
Material Changes
The material change reported is the voluntary dismissal without prejudice of all claims in the lawsuit filed on November 26, 2013. The Plaintiffs filed this dismissal on December 2, 2013.
Outlook, Risks, and Management Commentary
Management notes that the lawsuit has been voluntarily dismissed without prejudice. The filing does not provide specific guidance, future outlook, or additional risk factors beyond the status of this specific litigation.
Key Facts for Investor Verification
- The lawsuit filed by Prescott Group Capital Management against PharmAthene, Inc. was voluntarily dismissed without prejudice on December 2, 2013.
- The dismissal was filed in the Court of Chancery of the State of Delaware.
- The filing does not contain financial results or operational metrics.
- The company name in the source text is PharmAthene, Inc., which differs from the metadata request for Altimmune, Inc.